BlueLinx (US:BXC)2025-07-30 14:00Q2 2025 Financial Performance - Net sales increased by 1.5% year-over-year to $780 million[21] - Gross profit decreased by 2.3% year-over-year to $120 million[21] - Gross margin decreased by 60 bps year-over-year to 15.3%[21] - Adjusted EBITDA decreased by 22% year-over-year to $26.8 million, representing 3.4% of net sales[21] - Free cash flow was negative $36 million[21] Segment Performance - Specialty product net sales increased by 1% to $543 million, representing approximately 70% of total net sales[25] - Structural product net sales increased by 3% to $237 million[28] - Specialty product gross profits represent approximately 84% of total gross profit[25] - Structural product gross profits represent approximately 16% of total gross profit[28] Balance Sheet and Liquidity - Cash and cash equivalents totaled $387 million at the end of Q2 2025[34] - Total available liquidity was $730 million[34] - Net debt was negative $11 million, resulting in a net leverage ratio of (0.1x)[34]